Vivera Offers Solution Beyond Teva’s Recent $4.35B Opioid Settlement
NEWPORT BEACH, Calif—Amid government settlement discussions with Teva Pharmaceuticals regarding its potential role in the opioid crisis, Vivera invites Teva to join as a partner in the development of ZICOH, the Company’s patented, dose-controlled, electronic drug delivery medical device designed to solve the opioid crisis. LEARN MORE ABOUT ZICOH This invitation comes after Teva Pharmaceuticals […]
Vivera Appoints Dr. Guido Jouret as Interim Chief Technology Officer
NEWPORT BEACH, Calif. — Vivera is pleased to announce the appointment of Guido Jouret, Ph.D., to the Company’s Board of Advisors as Senior Technology Advisor and Interim Chief Technology Officer. In preparation for Vivera’s next phase of growth and development, focused on science, medical, and technology-driven products, the Company has strategized to establish a strong Technology […]
Vivera Welcomes Two Veteran Advisors to Its Technology Board
NEWPORT BEACH, Calif. — Vivera is pleased to welcome two Advisors to the Company’s Technology Advisory Board, Mr. Robert Massoudi and Mr. Bryan Hughes. Mr. Massoudi and Mr. Hughes will support Vivera in its product and software development initiatives, and forge strategic partnerships for ZICOH, the Company’s high-tech, electronic, dose-controlled medication delivery system designed to […]
Vivera Appoints Dr. Fabio Macciardi as Neurogenetics Scientific Advisor
NEWPORT BEACH, Calif. — Vivera Pharmaceuticals is pleased to welcome Fabio Macciardi, M.D., Ph.D., to its Advisory Board as Neurogenetics Scientific Advisor to the Company’s Biosciences Division. As an expert in neurogenetics, Dr. Macciardi will assist Vivera in the research and development of targeted genetic therapies to address the unmet needs of patients with various central nervous […]
Vivera Receives 3rd U.S. Patent Allowance for ZICOH Drug Delivery Device
NEWPORT BEACH, Calif.— Vivera is pleased to announce the allowance of its third U.S. patent for ZICOH, the Company’s high-tech, electronic dose-controlled portfolio of drug delivery devices. The patent allowance from the U.S. Patent and Trademark Office (USPTO) secures ZICOH’s rights as a smart dosing system with automated delivery, measurement, and management for oral format […]
Vivera Partners with NINDS of NIH to Identify Potential Stuttering Treatments
Vivera Executes Letter of Intent to Enter a Cooperative Research and Development Agreement with the NINDS of NIH to Assess Therapeutic Agents for Potential Treatments of Stuttering Disorders NEWPORT BEACH, Calif.—Vivera Biosciences, a division of Vivera Pharmaceuticals dedicated to the research and development of innovative medical technologies and pharmaceutical therapies, is pleased to announce its […]
5 Reasons Telemedicine is the Future of Health Care
Telemedicine involves the use of electronic communications and software like computers, video, phones, or messaging to provide clinical services to patients virtually. Telemedicine can effectively be used for various applications, including follow-up visits, chronic condition monitoring, medication management, and consultations. Here are a few benefits of incorporating telemedicine into our current health care system. Benefits […]
Opioid Poisoning in Young Children: What You Should Know
Poisoning can happen to people of all ages, but incidences disproportionately affect children younger than six years old, with peak poison frequency occurring in one and two-year-olds. Here are a few things to know about opioid poisoning in young children and a few preventative measures you can take to keep your kids safe. Poisoning and Children According […]
Vivera Enters $23 Billion Telehealth Industry with Patent Allowance for MDZone
NEWPORT BEACH, Calif. — Vivera Pharmaceuticals, Inc. is pleased to announce that it has received a Notice of Allowance for U.S. Patent Application No. 17/066,985 entitled, “Self-Contained, Portable, Sanitization Device and Telemedicine Station,” for the Company’s MDZone platform from the United States Patent and Trademark Office (USPTO). This Notice of Allowance indicates that the patent […]
Opioid Use Among Teens: Let’s Talk About It
Opioids are medications prescribed by doctors to treat pain. They are called opioids because they attach to the opioid receptors in the brain and throughout other parts of the body to block pain messages. While these drugs can effectively alleviate pain, they can be highly addictive, especially among teens whose brains aren’t fully developed yet. Opioids […]
